Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AMGN:US

164.3050 USD 1.7150 1.05%

As of 20:10:00 ET on 03/30/2015.

Snapshot for Amgen Inc (AMGN)

Open: 164.5100 Day's Range: 163.0500 - 165.8200 Volume: 2,388,057
Previous Close: 162.5900 52wk Range: 108.2000 - 173.1400 1-Yr Rtn: +35.80%

Stock Chart for AMGN

No chart data available.
  • AMGN:US 164.3050
  • 1D
  • 1M
  • 1Y
162.5900
Interactive AMGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AMGN

Current P/E Ratio (ttm) 22.5013
Estimated P/E(12/2015) 17.6293
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) 7.3020
Est. EPS (USD) (12/2015) 9.3200
Est. PEG Ratio 1.6372
Market Cap (M USD) 124,684.71
Shares Outstanding (M) 758.86
30 Day Average Volume 3,358,499
Price/Book (mrq) 4.8467
Price/Sale (ttm) 6.2205
Dividend Indicated Gross Yield 1.92%
Cash Dividend (USD) 0.7900
Dividend Ex-Date 05/12/2015
5 Year Dividend Growth -
Next Earnings Announcement 04/21/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AMGN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AMGN

Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

Robert A Bradway "Bob"Chairman/President/CEOAnnette L SuchChief Accounting Officer
David W MelineExec VP/CFOAnthony C Hooper "Tony"Exec VP:Global Commercial Ops
More Company Profile & Key Executives for AMGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil